This site is intended for healthcare professionals only
LoginRegister
C4 Therapeutics, Roche Ink USD 1 Billion Cancer Drug Deal for Novel DAC TherapiesRoche Drops Muscle Disease Drug After Trial Failure
Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin LymphomaBristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma
CDSCO Flags Illegal Manufacturing of Sodium Hyaluronate Eye Drops, Seeks Immediate ActionCDSCO Flags Illegal Manufacturing of Sodium Hyaluronate Eye Drops, Seeks Immediate Action
CDSCO Panel Opines Key Changes in Phase III Study of Glimepiride-Linagliptin FDCCDSCO Panel Recommends Key Changes in Phase III Study of Glimepiride-Linagliptin FDC
Centre Issues Medical Devices Amendment Rules 2026Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical...
Govt Panel Drops Plan to Ban Ads on Schedule G Drugs, Cites Alternative ApproachGovt Panel Drops Plan to Ban Ads on Schedule G Drugs, Cites Alternative Approach
Cipla Appoints New SMPs as Umang Vohra Steps DownCipla Announces Leadership Change, USD 100 Million Investment, Approves Inzpera Merger
AstraZeneca to Set Up Cell Therapy Hub in Shanghai, Expands CAR-T Capabilities in ChinaAstraZeneca to Set Up Cell Therapy Hub in Shanghai, Expands CAR-T Capabilities in China
J.B. Chemicals CEO Nikhil Chopra ResignsJB Pharma slapped Rs 80.81 Lakh Penalty for GST Violations
After Deadly ICU Fire, Orissa HC Orders Statewide Review of Hospital SafetyCalcutta HC Upholds WB Pharmacy Council Reconstitution, Rejects Member's Tenure Claim
CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease ApprovalsCDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease Approvals
NCLT Approves Merger of Shilpa Therapeutics with Shilpa MedicareNCLT Approves Merger of Shilpa Therapeutics with Shilpa Medicare
X